These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2141513)

  • 41. Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells.
    de Launoit Y; Veilleux R; Dufour M; Simard J; Labrie F
    Cancer Res; 1991 Oct; 51(19):5165-70. PubMed ID: 1913642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neither fibroblast growth factor-1 nor fibroblast growth factor-2 is an androgen receptor coactivator in androgen-resistant prostate cancer.
    Shain SA
    Mol Urol; 2001; 5(3):121-30. PubMed ID: 11690559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The pure anti-androgen bicalutamide inhibits cyclin A expression both in androgen-dependent and -independent cell lines.
    Katayama H; Murashima T; Saeki Y; Nishizawa Y
    Int J Oncol; 2010 Mar; 36(3):553-62. PubMed ID: 20126974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth factors in human prostate cancer cells: implications for an improved treatment of prostate cancer.
    Knabbe C; Kellner U; Schmahl M; Voigt KD
    J Steroid Biochem Mol Biol; 1991; 40(1-3):185-92. PubMed ID: 1958519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cells.
    Donat SM; Powell CT; Israeli RS; Fair WR; Heston WD
    J Natl Cancer Inst; 1995 Jan; 87(1):41-6. PubMed ID: 7666462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP.
    Swinnen JV; Van Veldhoven PP; Esquenet M; Heyns W; Verhoeven G
    Endocrinology; 1996 Oct; 137(10):4468-74. PubMed ID: 8828509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulatory effect of suramin on the proliferation of human glioma cells.
    Kuratsu J; Kurino M; Fukunaga K; Miyamoto E; Ushio Y
    Anticancer Res; 1995; 15(4):1263-8. PubMed ID: 7654006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of insulin-like growth factor binding protein-3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cells.
    Peng L; Wang J; Malloy PJ; Feldman D
    Int J Cancer; 2008 Feb; 122(3):558-66. PubMed ID: 17918155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
    Hsieh TC; Wu JM
    Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of breast cancer growth by suramin.
    Vignon F; Prebois C; Rochefort H
    J Natl Cancer Inst; 1992 Jan; 84(1):38-42. PubMed ID: 1738172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
    Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM
    Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proliferation of a highly androgen-sensitive ductus deferens cell line (DDT1MF-2) is regulated by glucocorticoids and modulated by growth on collagen.
    Syms AJ; Norris JS; Smith RG
    In Vitro; 1983 Dec; 19(12):929-36. PubMed ID: 6662552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
    Coffey RJ; Leof EB; Shipley GD; Moses HL
    J Cell Physiol; 1987 Jul; 132(1):143-8. PubMed ID: 3496343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of suramin alone or in combination with DHT and PDGF on the cell proliferation of benign and malignant human prostatic tissues in organ cultures.
    Michel P; Van Velthoven R; Petein M; Gras S; Etievant C; Pasteels JL; Kiss R
    Anticancer Res; 1991; 11(6):2075-8. PubMed ID: 1723262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen stimulated elevation in androgen receptor levels is inhibited by the synthetic glucocorticoid triamcinolone acetonide.
    Syms AJ; Norris JS; Smith RG
    Biochem Biophys Res Commun; 1983 Nov; 116(3):1020-5. PubMed ID: 6606427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin.
    Lopez Lopez R; van Rijswijk RE; Wagstaff J; Pinedo HM; Peters GJ
    Eur J Cancer; 1994; 30A(10):1545-9. PubMed ID: 7833116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines.
    Ivanov NI; Cowell SP; Brown P; Rennie PS; Guns ES; Cox ME
    Clin Nutr; 2007 Apr; 26(2):252-63. PubMed ID: 17337101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiproliferative effect of a prostatic cell-derived activity on the human androgen-dependent prostatic carcinoma cell line LNCaP.
    Abolhassani M; Chiao JW
    J Interferon Cytokine Res; 1995 Feb; 15(2):179-85. PubMed ID: 8590322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of suramin on the proliferation of primary epithelial cell cultures derived from normal, benign hyperplastic and cancerous human prostates.
    Mitchen J; Rago R; Wilding G
    Prostate; 1993; 22(1):75-89. PubMed ID: 7678932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.